GSK plc (NYSE:GSK) is one of the 11 best European stocks to invest in. On June 24, the company announced receipt of FDA ...

The US Food and Drug Administration (FDA) has approved the belimumab 200 mg/mL autoinjector for children aged 5 years of older with active lupus nephritis (LN) who are receiving standard therapy.

Hangzhou Qihan Biotech Co., Ltd. ("Qihan" or "Qihan Biotech" or "the Company"), an industry leader in applying multiplexable genome editing technology to cell therapies and organ transplantation, ...

The US FDA has approved GSK's 200 mg/ml autoinjector of Benlysta for individuals aged five years and above with active lupus ...

GSK’s approval expands belimumab treatment options, offering a first-of-its-kind subcutaneous option that can be administered ...

He, L., Zhou, Y., Wang, Q.T., Liu, J. and Ma, J.P. (2025) Two Pathological Patterns in Different Stages of the Same Disease. Journal of Biosciences and Medicines, 13, 189-195. doi: ...

When small B lymphocytes bind antigen in the context of suitable signals, a profound geno-proteomic metamorphosis is activated that generates antibody-secreting cells. To study the metabolic changes ...

PURPOSECurrent guidelines for the management of metastatic non–small cell lung cancer ... Plasma Proteome–Based Test for First-Line Treatment Selection in Metastatic Non ... however, 89.5% (483/540) ...

Similar to T cells, they are a type of white blood cell called lymphocytes. However, B cells and T cells differ in the sense that B cells produce antibodies to attack invading bacteria, ... It has ...

Around 90% of the plasma that reaches tissues from the arterial blood capillaries returns through the venous capillaries and veins. ... There are two types of lymphocytes: T cells and B cells.